BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28975394)

  • 1. Plasma L-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction.
    Sandqvist A; Schneede J; Kylhammar D; Henrohn D; Lundgren J; Hedeland M; Bondesson U; Rådegran G; Wikström G
    Heart Vessels; 2018 Mar; 33(3):255-263. PubMed ID: 28975394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.
    Henrohn D; Sandqvist A; Egeröd H; Hedeland M; Wernroth L; Bondesson U; Wikström G
    Vascul Pharmacol; 2015 Oct; 73():71-7. PubMed ID: 25934511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.
    Fang ZF; Huang YY; Tang L; Hu XQ; Shen XQ; Tang JJ; Zhou SH
    Pediatr Cardiol; 2015 Jun; 36(5):1062-9. PubMed ID: 25737007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mass spectrometry-based method for simultaneous determination of asymmetric and symmetric dimethylarginine, l-arginine and l-citrulline optimized for LC-MS-TOF and LC-MS/MS.
    Wiśniewski J; Fleszar MG; Piechowicz J; Krzystek-Korpacka M; Chachaj A; Szuba A; Lorenc-Kukula K; Masłowski L; Witkiewicz W; Gamian A
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28436051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E; Karadag CH; Guldiken S
    J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry.
    Martens-Lobenhoffer J; Bode-Böger SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():140-3. PubMed ID: 22884474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction.
    Lehmann HI; Goette A; Martens-Lobenhoffer J; Hammwöhner M; Röhl FW; Bukowska A; Ghanem A; Klein HU; Bode-Böger SM
    Europace; 2011 Oct; 13(10):1428-35. PubMed ID: 21752828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
    J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantitative determination of N(G),N(G)-dimethyl-L-arginine or asymmetric dimethylarginine and related pathway's metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Di Gangi IM; Chiandetti L; Gucciardi A; Moret V; Naturale M; Giordano G
    Anal Chim Acta; 2010 Sep; 677(2):140-8. PubMed ID: 20837180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection.
    Parikh RV; Scherzer R; Nitta EM; Leone A; Hur S; Mistry V; Macgregor JS; Martin JN; Deeks SG; Ganz P; Hsue PY
    AIDS; 2014 Feb; 28(4):511-9. PubMed ID: 24469026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.
    Shafran I; Probst V; Panzenböck A; Sadushi-Kolici R; Gerges C; Wolzt M; Segel MJ; Celermajer DS; Lang IM; Skoro-Sajer N
    JACC Heart Fail; 2024 Jun; 12(6):1089-1097. PubMed ID: 38573264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Sfetsios T; Karvounis H; Dimitroula H; Koliakos G; Settas L
    Rheumatology (Oxford); 2008 Nov; 47(11):1682-5. PubMed ID: 18753191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
    Paroni R; Barassi A; Ciociola F; Dozio E; Finati E; Fermo I; Ghilardi F; Colpi GM; Corsi MM; Melzi d'Eril GV
    Int J Androl; 2012 Oct; 35(5):660-7. PubMed ID: 22519580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-related biomarkers in pulmonary hypertension patients on oral therapies.
    Swaminathan AC; Zhu H; Tapson V; Lokhnygina Y; Poms A; Kelleher Z; Gaspard E; Kennedy K; Fee BE; Fortin T; Mason SN; Parikh K; McMahon TJ
    Respir Res; 2020 Nov; 21(1):304. PubMed ID: 33213478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
    Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
    COPD; 2016; 13(2):139-45. PubMed ID: 26514682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].
    Chen P; Huang Y; Fang Z; Hu X; Shen X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):35-40. PubMed ID: 28216495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.